Application of PET/MRI in Gynecologic Malignancies

Sheida Ebrahimi,Elin Lundström,Summer J. Batasin,Elisabeth Hedlund,Karin Stålberg,Eric C. Ehman,Vipul R. Sheth,Negaur Iranpour,Stephane Loubrie,Alexandra Schlein,Rebecca Rakow-Penner
DOI: https://doi.org/10.3390/cancers16081478
2024-04-12
Cancers
Abstract:The diagnosis, treatment, and management of gynecologic malignancies benefit from both positron emission tomography/computed tomography (PET/CT) and MRI. PET/CT provides important information on the local extent of disease as well as diffuse metastatic involvement. MRI offers soft tissue delineation and loco-regional disease involvement. The combination of these two technologies is key in diagnosis, treatment planning, and evaluating treatment response in gynecological malignancies. This review aims to assess the performance of PET/MRI in gynecologic cancer patients and outlines the technical challenges and clinical advantages of PET/MR systems when specifically applied to gynecologic malignancies.
oncology
What problem does this paper attempt to address?
The main purpose of this paper is to evaluate the application of Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) in gynecological malignancies and to outline its technical challenges and clinical advantages. Specifically: 1. **Evaluate the performance of PET/MRI**: The paper aims to assess the performance of PET/MRI in patients with gynecological cancers, particularly its capabilities in diagnosis, treatment planning, and evaluating treatment response. 2. **Comparative analysis**: The paper also provides a comparative analysis of PET/MRI with other imaging modalities (such as PET/CT and MRI), exploring their respective advantages and disadvantages. 3. **Technical introduction**: The paper introduces relevant information about PET/MRI technology, including system design, biomarkers, advantages, challenges, and prospects. 4. **Improve diagnostic accuracy**: By combining the advantages of PET and MRI, PET/MRI can provide complementary information, thereby improving the diagnostic accuracy of detecting pelvic malignancies. 5. **Reduce radiation exposure**: Compared to PET/CT, PET/MRI can significantly reduce radiation exposure to patients, making it particularly suitable for those requiring multiple follow-up examinations or those sensitive to radiation (such as children or women of childbearing age). 6. **Increase diagnostic confidence**: PET/MRI has higher diagnostic confidence in distinguishing between benign and malignant lesions compared to PET/CT and shows higher predictive ability in recurrent female pelvic malignancies. In summary, this paper aims to provide theoretical support and technical guidance for the promotion of PET/MRI in clinical practice through a comprehensive evaluation of its application in gynecological malignancies.